TY - JOUR T1 - CoMix: comparing mixing patterns in the Belgian population during and after lockdown JF - medRxiv DO - 10.1101/2020.08.06.20169763 SP - 2020.08.06.20169763 AU - Pietro Coletti AU - James Wambua AU - Amy Gimma AU - Lander Willem AU - Sarah Vercruysse AU - Bieke Vanhoutte AU - Christofer I Jarvis AU - Kevin Van Zandvoort AU - John Edmunds AU - Philippe Beutels AU - Niel Hens AU - on behalf of the SIMID-COVID19 Team Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/07/2020.08.06.20169763.abstract N2 - Background The COVID-19 pandemic has shown how a newly emergent communicable disease can lay considerable burden on public health. To avoid system collapse, governments have resorted to several social distancing measures. In Belgium, this included a lockdown and a following period of phased re-opening.Methods A representative sample of Belgian adults was asked about their contact behaviour from mid-April to mid-July, during different stages of the intervention measures in Belgium. Use of personal protection equipment (face masks) and compliance to hygienic measures was also reported. We estimated the expected reproduction number computing the ratio of R0 with respect to pre-pandemic data.Findings During the first two waves (the first month) of the survey, the reduction in the average number of contacts was around 80% and was quite consistent across all age-classes. The average number of contacts increased over time, particularly for the younger age classes, still remaining significantly lower than pre-pandemic values. Since the end of May, the estimated reproduction number has a median value larger than one, although with a wide dispersion.Conclusions We have shown how a rapidly deployed survey can measure compliance to social distancing and assess its impact on COVID-19 spread. Monitoring the effectiveness of social distancing recommendations is of paramount importance to avoid further waves of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement 682540 TransMID). This project was funded by the European Union's Horizon 2020 Research and Innovations Programme - project EpiPose (Epidemic intelligence to Minimize COVID-19's Public Health, Societal and Economical Impact. LW gratefully acknowledge support from the Fonds voor Wetenschappelijk Onderzoek (FWO) (postdoctoral fellowship 1234620N).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Participants (aged 18 years or older) opt-in for the study voluntarily. All analyses were performed on pseudo-anonymised data. The study was approved by the ethics committee of the University of Antwerp (reference number EC UZA 20/13/147).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data for individual contacts is available on Zenodo. ER -